Company news and developments, with original sources and dates.
Updated from source·Oct 20, 2026, 18:05 UTC
On 2026-07-22, according to Xiniu Data, Yuanmazhiyao completed Pre-Series A financing, raising tens of millions of RMB. Investors were Yifeng Capital, Yingxi Intelligence and others. The company is a developer of circular mRNA-based in vivo CAR-T therapies.